NEXTCURE INC's ticker is NXTC and the CUSIP is 65343E108. A total of 86 filers reported holding NEXTCURE INC in Q4 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,165,421 | -28.7% | 903,427 | -0.6% | 0.00% | – |
| Q2 2023 | $1,635,252 | +21.6% | 908,473 | 0.0% | 0.00% | – |
| Q1 2023 | $1,344,540 | +5.0% | 908,473 | 0.0% | 0.00% | – |
| Q4 2022 | $1,280,947 | -48.7% | 908,473 | +0.0% | 0.00% | – |
| Q3 2022 | $2,498,000 | -43.1% | 908,144 | -2.8% | 0.00% | – |
| Q2 2022 | $4,392,000 | +31.0% | 934,355 | +35.5% | 0.00% | – |
| Q1 2022 | $3,353,000 | -25.6% | 689,781 | -8.2% | 0.00% | – |
| Q4 2021 | $4,509,000 | -17.1% | 751,569 | -6.8% | 0.00% | – |
| Q3 2021 | $5,438,000 | -15.9% | 806,813 | +0.2% | 0.00% | – |
| Q2 2021 | $6,466,000 | -23.5% | 805,227 | -4.6% | 0.00% | – |
| Q1 2021 | $8,452,000 | +6.3% | 844,283 | +15.7% | 0.00% | – |
| Q4 2020 | $7,954,000 | +31.4% | 729,610 | +6.0% | 0.00% | – |
| Q3 2020 | $6,054,000 | -58.5% | 688,005 | +1.1% | 0.00% | -100.0% |
| Q2 2020 | $14,587,000 | -34.9% | 680,368 | +12.5% | 0.00% | 0.0% |
| Q1 2020 | $22,416,000 | -30.0% | 604,710 | +6.4% | 0.00% | 0.0% |
| Q4 2019 | $32,007,000 | +349.0% | 568,204 | +145.9% | 0.00% | – |
| Q3 2019 | $7,129,000 | +262.4% | 231,081 | +76.0% | 0.00% | – |
| Q2 2019 | $1,967,000 | – | 131,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 721,302 | $4,862,000 | 2.75% |
| Sofinnova Investments, Inc. | 2,671,856 | $18,008,000 | 1.07% |
| Canaan Partners X LLC | 321,647 | $2,168,000 | 0.62% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $2,022,000 | 0.42% |
| Diametric Capital, LP | 76,162 | $513,000 | 0.40% |
| Lion Point Capital, LP | 300,000 | $2,022,000 | 0.38% |
| DAFNA Capital Management LLC | 183,491 | $1,237,000 | 0.33% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 217,139 | $1,464,000 | 0.25% |
| Ikarian Capital, LLC | 509,155 | $3,431,000 | 0.24% |
| Orbimed Advisors | 2,711,013 | $18,272,000 | 0.20% |